
Cyclacel Pharmaceuticals CYCCP
Annual report 2024
added 11-26-2025
Cyclacel Pharmaceuticals DPO Ratio 2011-2026 | CYCCP
Annual DPO Ratio Cyclacel Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | 1.79 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.79 K | 1.79 K | 1.79 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.79 | - | $ 4.31 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
BioCardia
BCDA
|
68.1 K | $ 1.29 | 1.57 % | $ 27.3 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 14.36 | - | $ 210 M | ||
|
AVEO Pharmaceuticals
AVEO
|
235 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.64 | - | $ 16.6 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B |